Thrivent Financial For Lutherans Novartis Ag Transaction History

Thrivent Financial For Lutherans

  • $51.6 Billion
  • Q4 2024

A detailed history of Thrivent Financial For Lutherans transactions in Novartis Ag stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 1,933 shares of NVS stock, worth $203,796. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,933
Holding current value
$203,796
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025
BUY
$96.78 - $117.18 $187,075 - $226,508
1,933 New
1,933 $204,000
Q1 2023

May 17, 2023
SELL
$80.03 - $92.81 $5,922 - $6,867
-74 Reduced 3.12%
2,301 $212,000
Q4 2022

Feb 08, 2023
BUY
$75.55 - $92.52 $179,431 - $219,735
2,375 New
2,375 $215,000
Q2 2022

Aug 16, 2022
SELL
$80.52 - $93.75 $244,861 - $285,093
-3,041 Reduced 56.15%
2,375 $201,000
Q1 2022

May 13, 2022
BUY
$80.11 - $90.62 $433,875 - $490,797
5,416 New
5,416 $475,000
Q1 2021

May 17, 2021
SELL
$83.5 - $98.47 $224,531 - $264,785
-2,689 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$78.07 - $94.43 $209,930 - $253,922
2,689 New
2,689 $254,000
Q3 2020

Nov 10, 2020
SELL
$82.14 - $91.0 $223,667 - $247,793
-2,723 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$70.67 - $99.01 $23,109 - $32,376
327 Added 13.65%
2,723 $225,000
Q4 2019

Feb 13, 2020
SELL
$84.35 - $95.37 $138,080 - $156,120
-1,637 Reduced 40.59%
2,396 $227,000
Q3 2019

Nov 14, 2019
BUY
$85.54 - $94.26 $344,982 - $380,150
4,033 New
4,033 $350,000
Q4 2017

Feb 14, 2018
SELL
$72.33 - $77.64 $4,339 - $4,658
-60 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$74.14 - $77.27 $4,448 - $4,636
60
60 $5,000

Others Institutions Holding NVS

# of Institutions
1,468
Shares Held
134M
Call Options Held
1.4M
Put Options Held
1.61M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $227B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email